References
- Pedersen CB, Olsen J. Danish approach to the treat-ment of secretory otitis media. Report of the Danish consensus conference. Ann Otol Rhinol Laryngol Suppl 1987; 99: 1–28.
- Lim DJ, Shimada T, Yoder M. Distribution of mucus-secreting cells in normal middle ear mucosa. Arch Otolaryngol 1973; 98: 2–9.
- PaIva T, PaIva A. Mucosal histochemistry in secretory otitis. Ann Otol Rhinol Laryngol 1975; 84: 112–6.
- Tos M, Bak Pedersen K. Density of goblet cells in chronic secretory otitis media: findings in a biopsy material. Laryngoscope 1975; 85: 377–83.
- Kuijpers W, Van der Beek JMH, Willart ECT. The effect of experimental tubal obstruction on the middle ear. Acta Otolaryngol 1979; 87: 345–52.
- Kiroglu F, Kaya M, Ozsahinoglu C, Soylu L, Polat S. Changes of middle ear mucosa in secretory otitis media treated with ventilation tubes. Acta Otolaryngol 1990; 110: 266–73.
- Carrie S, Hutton DA, Birchall JP, Green GG, Pearson JP. Otitis media with effusion: components which con-tribute to the viscous properties. Acta Otolaryngol 1992; 112: 504–11.
- Kubba H, Pearson JP, Birchall JP. The aetiology of otitis media with effusion: a review. Clin Otolaryngol 2000; 25: 181–94.
- Perez-Vilar J, Hill RL. The structure and assembly of secreted mucins. J Biol Chem 1999; 274: 31751–4.
- Cantekin El, Phillips DC, Doyle WJ, Bluestone CD, Kimes KK. Effect of surgical alterations of the tensor veli palatini muscle on eustachian tube function. Ann Otol Rhinol Laryngol Suppl 1980; 89: 47–53.
- Yamanaka N, Somekawa Y, Suzuki T, Kataura A. Immunologic and cytologic studies in otitis media with effusion. Acta Otolaryngol 1987; 104: 481–6.
- Harkness P, Topham J. Classification of otitis media. Laryngoscope 1998; 108: 1539–43.
- Kim KC, McCracken K, Lee BC, et al. Airway goblet cell mucin: its structure and regulation of secretion. Eur Respir J 1997; 10: 2644–9.
- Harada T, Kim Y, Juhn SK, Sakakura Y. Biochemical characterization of mucous glycoproteins secreted by in vitro chinchilla middle ear epithelial cells. Eur Arch Otorhinolaryngol 1993; 250: 182–5.
- FitzGerald JE, Green GG, Stafford FW, Birchall JP, Pearson JP. Characterization of human middle ear mucus glycoprotein in chronic secretory otitis media (CSOM). Clin Chim Acta 1987; 169: 281–97.
- Brown DT, Litt M, Potsic WP. A study of mucus glycoproteins in secretory otitis media. Arch Otolaryn-gol 1985; 111: 688–95.
- Hutton DA, Guo L, Birchall JP, Severn TL, Pearson JP. MUC5B expression in middle ear mucosal glands. Biochem Soc Trans 1998; 26: S117.
- Hutton DA, Fogg FJ, Kubba H, Birchall JP, Pearson JP. Heterogeneity in the protein cores of mucins iso-lated from human middle ear effusions: evidence for expression of different mucin gene products. Glycoconj J 1998; 15: 283–91.
- Kawano H, Paparella MM, Ho SB, et al. Identification of MUC5B mucin gene in human middle ear with chronic otitis media. Laryngoscope 2000; 110: 668–73.
- Lin J, Kim Y, Lees C, Juhn SK. Effects of platelet-ac-tivating factor (PAF) receptor blockage on mucous glycoprotein secretion in cultured chinchilla middle ear epithelium. Acta Otolaryngol 1996; 116: 69–73.
- Beck-Schimmer B, Schimmer RC, Warner RL, et al. Expression of lung vascular and airway ICAM-1 after exposure to bacterial lipopolysaccharide. Am J Respir Cell Mol Biol 1997; 17: 344–52.
- van de Stolpe A, van der Saag PT. Intercellular adhe-sion molecule-1. J Mol Med 1996; 74: 13–33.
- Ohashi Y, Nakai Y, Tanaka A, Kakinoki Y, Washio Y. Soluble adhesion molecules in middle ear effusions from patients with chronic otitis media with effusion. Clin Otolaryngol 1998; 23: 231–4.
- Beutler B, Cerami A. The history, properties, and biological effects of cachectin. Biochemistry 1988; 27: 7575–82.
- Caye-Thomasen P, Hermansson A, Tos M, Prellner K. Increased secretory capacity of the middle ear mucosa after acute otitis media caused by Haemophilus influen-zae type B. Otolaryngol Head Neck Surg 1997; 117: 263–7.